Mice. C57BL/6J (CD45.2 + ) and B6.SJL-Ptprc a Pepc b /BoyJ (B6.SJL, CD45.1 + ) mice were purchased from the Jackson Laboratory and bred in house. C57BL/ 6j:B6.SJL hybrids (CD45.2 + CD45.1 + ) were generated by breeding C57BL/6J with B6.SJL mice. Ubc-gfp mice 41 , Mrp8-cre-IRES-gfp (Mrp8-cre) 42 , iDTR 43 and Tnfa −/− (ref. 44) mice were originally purchased from the Jackson laboratory. Tnfr1 −/− ; Tnfr2 −/− (ref. 45) mice were also purchased from the Jackson Laboratory and then backcrossed for four additional generations into the C57BL/6J background and bred in house. Nestin-gfp mice 18,29 were provided by P.S.F. All experiments were performed in 8-to 14-week-old male mice. All mice were housed at the SPF facility managed by the Unit for Laboratory Animal Medicine (ULAM) at the University of Michigan. Experiments complied with all relevant ethical regulations and were approved by the Institutional Animal Care and Use Committee at the University of Michigan.
l e t t e r S Endothelial cells are a critical component of the bone marrow (BM) stromal network, which maintains and regulates hematopoietic cells [1] [2] [3] [4] [5] [6] [7] [8] [9] . Vascular regeneration precedes, and is necessary for, successful hematopoietic stem cell (HSC) transplantation, the only cure for most hematopoietic diseases 2, 4 . Recent data suggest that mature hematopoietic cells regulate BM stromal-cell function [10] [11] [12] [13] . Whether a similar cross-talk regulates the BM vasculature is not known. Here we found that donor hematopoietic cells act on sinusoidal endothelial cells and induce host blood vessel and hematopoietic regeneration after BM transplantation in mice. Adoptive transfer of BM, but not peripheral, granulocytes prevented the death of mice transplanted with limited numbers of HSCs and accelerated recovery of host vessels and hematopoietic cells. Moreover, selective granulocyte ablation in vivo impaired vascular and hematopoietic regeneration after BM transplantation. Gene expression analyses indicated that granulocytes are the main source of the cytokine TNFa, whereas its receptor TNFR1 is selectively upregulated in regenerating blood vessels. In adoptive transfer experiments, wild type, but not Tnfa −/− , granulocytes induced vascular recovery, and wild-type granulocyte transfer did not prevent death or promote vascular regeneration in Tnfr1 −/− ; Tnfr2 −/− mice. Thus, by delivering TNFa to endothelial cells, granulocytes promote blood vessel growth and hematopoietic regeneration. Manipulation of the cross-talk between granulocytes and endothelial cells may lead to new therapeutic approaches to improve blood vessel regeneration and increase survival and hematopoietic recovery after HSC transplantation.
Blood-cell production takes place in the BM, where a network of nonhematopoietic stromal cells provides a unique microenvironment that maintains and regulates differentiating hematopoietic cells 14 . The endothelial cells that form the blood vessels of the BM are key constituents of this stromal network and produce angiocrine factors such as CXCL12, SCF, pleiotrophin and Notch ligands, which regulate HSCs and progenitors 1, [6] [7] [8] [9] 15, 16 , and other stromal cells 6 . Endothelial cells also play a critical role after HSC transplantation by producing angiocrine factors that promote hematopoietic regeneration 1, 3, 4, 16, 17 . The myeloablative treatments used to eliminate host hematopoietic cells severely damage BM blood vessels 2, 4, 18 , which must regenerate before they can support hematopoiesis 2, 4, 19 . Therapies that promote vessel survival or regeneration also promote hematopoietic recovery 2, 4, 19 . Recent studies have shown that mature hematopoietic cells such as macrophages [11] [12] [13] and peripheral blood neutrophils 10 regulate the function of BM osteoblastic stromal cells, but whether mature blood cells also regulate the BM vasculature remains unknown.
To test whether hematopoietic cells cross-talk with the vasculature in the context of BM transplantation and regeneration, we transplanted different amounts of CD45.2 + bone marrow nucleated cells (BMNCs) into lethally irradiated CD45.1 + recipient mice. Fourteen days later, the transplanted mice showed a dose-dependent increase in the numbers of hematopoietic and CD45 − Ter119 − CD31 + CD105 + endothelial cells in the BM (Fig. 1a,b and Supplementary Fig. 1a) .
To analyze the vascular network in these mice, we injected antibodies to CD31 and CD144 intravenously and then performed dissection and 3D whole-mount imaging of the sternal vasculature 18 . These procedures allowed us to distinguish between true vessels-those with a perfused lumen-and vascular sheets that appear after vascular injury (Supplementary Videos 1 and 2) . Transplantation with a higher number of BMNCs resulted in a denser vascular network with longer and more numerous vessels (Fig. 1c,d and Supplementary  Videos 1 and 2) . In agreement with these results, we found lower vascular permeability (as measured by Evans blue extravasation 20 ) in mice transplanted with a higher number of donor BMNCs (Fig. 1e) . To test whether the endothelial cells observed in the sternal vasculature after transplantation were host or donor derived, we transplanted wild-type (WT) mice with 20 × 10 6 BMNCs purified from Ubc-gfp mice, which constitutively express GFP in all cells. We did not detect GFP expression in endothelial cells of the recipients, indicating that virtually all endothelial cells were host derived ( Fig. 1f) . Transplantation of a 9 6 VOLUME 24 | NUMBER 1 | JANUARY 2018 nature medicine l e t t e r S higher number of BMNCs led to increased endothelial-cell recovery early after transplantation (Supplementary Fig. 1b ) and decreased fractions of necrotic endothelial cells ( Supplementary Fig. 1c ), but had no effect on the cycling of endothelial cells ( Supplementary  Fig. 1d ). These data demonstrate that donor hematopoietic cells promote endothelial-cell survival and drive the recovery of a functional, host-derived vascular network in the recipient mice.
These results were unexpected because hematopoietic progenitors have been reported to inhibit vascular regeneration via angiopoietin-1 (ref. 21) . We thus investigated whether the observed vascular recovery was mediated by hematopoietic cells that were more mature than the progenitors previously investigated. After FACS-purifying CD45.2 + hematopoietic cells into subpopulations on the basis of the expression of mature lineage markers, we adoptively transferred each of these subpopulations, together with 10 5 CD45.1 + BMNCs (as a source of donor HSCs), into gamma-irradiated CD45.2 + recipients; each subpopulation was transplanted at the same ratio as that present in vivo. Because adoptively transferred mature hematopoietic cells are thought to have limited self-renewal capacity in vivo, we adoptively transferred the same populations every 2 to 3 d for 2 weeks ( Fig. 2a) . Of the types of mature hematopoietic cells tested, only Gr1 + CD115 − granulocytes, which contain all BM neutrophils and late neutrophil progenitors 11 , induced rapid recovery of endothelial cells ( Fig. 2b) . Notably, granulocyte transfer also promoted survival of the recipient mice ( Fig. 2c ) and led to faster recovery of hematopoietic cells in the periphery (Fig. 2d) . In agreement with results from previous studies 2, 4, 19 demonstrating a strong correlation between endothelial-cell recovery and survival, we found that moribund mice showed less vascular recovery ( Supplementary Fig. 2a ). Imaging of the sternal vasculature showed that granulocyte-treated mice had more blood vessels than did PBS-treated controls or mice subjected to transfer with monocytes/macrophages, lymphocytes or erythroid-lineage cells ( Fig. 2e,f) . Granulocyte transfer also rescued vascular leakiness in irradiated mice, but only when very high doses were transferred ( Fig. 2g) . Granulocyte-induced recovery was not mediated by induction of systemic inflammation, because we did not detect significant increases in inflammatory-cytokine levels in the BM or plasma ( Supplementary Fig. 2b) ; injury to peripheral tissues, as assessed by pathology analyses (Supplementary Fig. 2c ); or increased granulocyte recruitment to peripheral tissues ( Supplementary Fig. 2d ). We also did not find increased endothelial-cell recovery in peripheral tissues in granulocyte-treated mice (Supplementary Fig. 2e ). The number of BMNCs (a) and endothelial cells (EC; CD45 − Ter119 − CD31 + CD105 + ) (b) in the femurs of B6-SJL mice 14 d after lethal irradiation and transplantation with the indicated numbers of CD45.2 + BMNCs (1 × 10 5 (n = 8), 5 × 10 5 (n = 5), 50 × 10 5 (n = 4), 200 × 10 5 (n = 6)). P values were calculated with a one-way analysis of variance (ANOVA) model comparing the three higher doses to the lowest dose. Each circle represents one mouse. (c) Representative composite image showing blood vessels (white, CD31 and CD144) in the sternum in mice treated as in a. Scale bar, 200 µm. Images are representative of three mice for each group in two different experiments. (d) Quantification of intact blood vessel segments (left, each circle represents one mouse, 1 × 10 5 (n = 4), 20 × 10 5 (n = 3)) or average vessel length (right, each circle represents one vessel, 1 × 10 5 (n = 19), 20 × 10 5 (n = 19)) in the sternums of mice treated as in a. P values were calculated with two-tailed two-sample t tests. (e) Quantification of extravasation of Evans blue dye in the BM extracellular fluid (BMEF) of mice treated as in a (1 × 10 5 (n = 5), 20 × 10 5 (n = 7)). P values were calculated with two-tailed two-sample t tests. (f) Percentage of GFP + cells in FACS analyses of hematopoietic (CD45 + ; gated as live singlets, CD45 + cells) or endothelial cells (gated as live singlets, CD45 − Ter119 − CD31 + CD105 + cells) in the BM of Ubc-gfp mice (left) or B6-SJL CD45.1 + recipients transplanted with 20 × 10 6 BMNCs purified from Ubc-gfp mice (right). The data show representative FACS plots out of 3 mice per group in two independent experiments. Throughout figure, bar graphs represent the means and show data for at least two independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant. l e t t e r S Transfer of common myeloid progenitors can protect lethally irradiated mice from death until the few host HSCs that survive irradiation can restore hematopoiesis 22 . To test whether granulocytes induce survival through a similar mechanism, we adoptively transferred granulocytes without accompanying BMNCs into lethally irradiated mice. In the absence of donor hematopoietic stem and progenitor cells (HSPCs), granulocytes were not capable of rescuing irradiationinduced death (Supplementary Fig. 2f ).
Next, we performed transfer of granulocytes together with BMNCs and followed vascular and hematopoietic recovery up to 4 weeks after transplantation ( Fig. 2h and Supplementary Fig. 3a,b) . These analyses revealed that, compared with transfer of BMNCs alone, granulocyte transfer promoted endothelial-cell survival early after transplantation, as evidenced by lower numbers of apoptotic and necrotic endothelial cells (Fig. 2i) ; this endothelial protection was comparable to that induced by transfer of a high number of BMNCs (Supplementary Fig.  1c ). Moreover, we found that granulocytes induced expression of Cflar (also known as cFlip), which encodes an antiapoptotic prosurvival factor 23 , in BM endothelial cells in vivo (Supplementary Fig. 3c ). In contrast, granulocytes did not induce expression of hematopoieticsupportive molecules such as CXCL12, Scf or Notch ligands, or lead to activation of hypoxia-inducible factor 1α or its downstream targets ( Supplementary Fig. 3d-f ). These results indicate that granulocytes promote endothelial-cell survival.
To further analyze the effect of granulocytes on hematopoietic recovery, we performed lineage tracing experiments ( Supplementary  Fig. 4a ). In granulocyte-treated mice, the increase in peripheral blood and BM hematopoietic recovery was associated with persistence of the transferred BM granulocytes ( Supplementary Fig. 4d,g) and increased production of host cells ( Supplementary Fig. 4c-h) . Notably, adoptive transfer of peripheral blood neutrophils, which home to the bone marrow, cross-talk with CXCL12-expressing reticular stromal cells and regulate HSC trafficking 10 , did not induce vascular or hematopoietic recovery ( Supplementary Fig. 4b-h ). Moreover, in contrast to BM granulocytes, these neutrophils did not persist in the recipient mice ( Supplementary Fig. 4d,g) . We hypothesized that greater vascular recovery might facilitate engraftment of donor-derived HSPCs. To test this concept, we performed competitive transplants. We FACS-purified donor CD45.1 + cells from primary recipients that had been transplanted with or without granulocytes and transplanted the CD45.1 + cells, together with competitor CD45.1 + CD45.2 + BMNCs, into lethally irradiated CD45.2 + secondary recipients ( Fig. 2a ). Mice transplanted with CD45.1 + BMNCs from granulocyte-treated mice, as compared with mice transplanted with CD45.1 + BMNCs purified from PBStreated mice, displayed higher short-term T and myeloid-cell, but not long-term (16 weeks) multilineage, CD45.1 + -cell contributions to the peripheral blood ( Fig. 2j) , indicating that granulocyte-induced vascular recovery promotes engraftment of short-lived, lineage-committed hematopoietic progenitors but not HSCs. Together, these results demonstrate that adoptive transfer of BM granulocytes is sufficient to promote survival and drive vascular-and hematopoietic-cell recovery after myeloablation, without exhausting the donor HSC pool.
Next, to test whether granulocytes produced by BMNC transplantation promote vascular regeneration, we bred MRP8-Cre-ires-GFP mice, in which Cre expression is largely restricted to granulocytes and a fraction of granulocyte monocyte progenitors (GMPs), with iDTR mice, in which the diphtheria-toxin receptor (DTR) is induced by Cre-mediated recombination. We transplanted lethally irradiated recipients with 5 × 10 6 BMNCs purified from iDTR or Mrp8-cre-IRES-GFP; iDTR mice, and then performed diphtheria-toxin treatment.
This strategy led to efficient granulocyte ablation in the recipient mice transplanted with Mrp8-cre-IRES-GFP; iDTR, but not control iDTR, BMNCs (Fig. 3a,b) . In the mice transplanted with Mrp8-cre-IRES-GFP; iDTR BMNCs, granulocyte ablation led to impaired vascular regeneration and increased vascular leakage ( Fig. 3c-e ) and impaired peripheral-blood-cell recovery (Fig. 3f) , and also decreased the numbers of monocytes and macrophages in the BM (Fig. 3g-i) .
To confirm that the monocyte/macrophage loss was not responsible for the decreased number of blood vessels, we ablated granulocytes in vivo by injection of anti-Ly6G, an antibody that ablates granulocytes exclusively 24 . Treatment with anti-Ly6G, but not an isotype-control antibody, depleted granulocytes ( Fig. 3j ) and impaired vascular regeneration (Fig. 3k) , and also caused loss of BM monocytes and lymphocytes ( Supplementary Fig. 5a,b) . In a complementary approach, we transplanted recipient mice with a single graft of total BMNCs or a graft in which the granulocytes were removed before transplantation via FACS. As expected, had mice transplanted with a granulocyte-depleted graft had fewer granulocytes ( Fig. 3l ) and showed impaired endothelial and hematopoietic regeneration 6 d after transplantation ( Fig. 3m and Supplementary Fig. 5c,d) . These experiments demonstrate that donor-derived granulocytes are necessary for efficient vascular regeneration.
To investigate the mechanisms through which granulocytes promote vascular regeneration, we profiled BM granulocytes for the expression of multiple angiogenic factors, as assessed by qPCR. We detected expression of fibroblast growth factor 1 (Fgf1), progranulin (Prgn), pleiotrophin (Ptn), vascular endothelial growth factor A (Vegfa) and TNFα (Tnfa) (Supplementary Fig. 6a ). We focused on TNFα because Tnfa transcripts were enriched in BM granulocytes ( Supplementary  Fig. 6b ), Tnfr1 (official symbol Tnfrsf1a, encoding TNFα receptor 1a) transcripts were enriched in endothelial cells compared with other BM stromal cells ( Supplementary Fig. 6c ), Tnfr1 was upregulated in regenerating endothelial cells ( Supplementary Fig. 6c ), and TNFα is known to induce cFLIP expression 25 . TNFα is a powerful angiogenic factor in mice 26, 27 , and neutrophil-derived TNFα drives blood vessel formation during zebrafish development 28 . Analyses of Tnfa −/− or Tnfr1 −/− ; Tnfr2 −/− mice revealed fewer endothelial cells in the steadystate bone marrow ( Supplementary Fig. 7) , indicating that TNFα regulates vascular homeostasis.
To test whether TNFα also plays a role in regeneration, we myeloablated WT or Tnfa −/− mice with a single injection of 5-fluorouracil. As compared with WT mice, Tnfa −/− mice displayed fewer BM endothelial cells and exhibited a rapidly decrease in survival in response to this treatment ( Fig. 4a,b) . The lower survival of Tnfa −/− mice suggested a defect in endothelial regeneration but might also have been due to fewer BM endothelial cells in the steady state. Moreover, injection of recombinant TNFα induced faster vascular recovery in 5-fluorouraciltreated WT and Tnfa −/− mice and delayed death in Tnfa −/− mice ( Fig. 4a,b) . These results indicate that TNFα is needed for normal BM endothelial cell numbers during homeostasis and that TNFα directly promotes endothelial regeneration.
BM granulocytes expressed the membrane-bound form of TNFα, as assessed by flow cytometry (Supplementary Fig. 8a) . To test whether granulocytes promote vascular regeneration specifically via TNFα production, we performed adoptive transfer experiments using granulocytes purified from WT and Tnfa −/− mice. To distinguish between the regenerative effects of granulocytes on sinusoids and arterioles, we used Nestin-gfp mice; in this model, cells with high GFP expression (Nestin-GFP bright ) label arterioles 18, 29 . WT but not Tnfa −/− granulocytes induced sinusoidal-vessel recovery, as demonstrated by . P values were calculated with a one-way ANOVA model. (h) Percentage of granulocytes (n = 305 granulocytes in two mice) found at the indicated distances from sinusoids (black) or arterioles (white) in Nestin-gfp mice 6 d after lethal irradiation and transplantation of 10 6 BMNCs. Bar graphs show pooled data for two mice in two independent experiments. (i) Immunofluorescence analyses showing the association between transferred granulocytes (magenta, Ly6G) with regenerating sinusoids (white, CD31/CD144) and arterioles (white and green, CD31/CD144 + Nestin-GFP bright ) in the mice shown in h. Scale bar, 25 µm. Images are representative of those from 2 mice in two independent experiments. (j) Survival curves for WT and Tnfr1 −/− ; Tnfr2 −/− mice after lethal irradiation and transplantation of 10 5 CD45.1 + BMNCs and subsequent treatment with PBS (WT (n = 13), Tnfr1 −/− ; Tnfr2 −/− (n = 4)) or adoptive transfer of WT granulocytes (WT (n = 12), Tnfr1 −/− ; Tnfr2 −/− (n = 6)). P values were calculated with log-rank analyses. (k) Number of endothelial cells in mice treated as in j, but 6 d after the initial transplant (WT + PBS (n = 5), WT + granulocytes (n = 5), Tnfr1 −/− ; Tnfr2 −/− + PBS (n = 5), Tnfr1 −/− ; Tnfr2 −/− + Gran (n = 5)). P values were calculated with a one-way ANOVA model. In all panels (except h), graphs show pooled data from at least two independent experiments, and bar graphs show means. Error bars, standard error. *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant. l e t t e r S nature medicine VOLUME 24 | NUMBER 1 | JANUARY 2018 1 0 1 quantification of endothelial cells by FACS ( Fig. 4c) and sinusoidal and arteriolar vessel numbers by 3D whole-mount immunofluorescence ( Fig. 4d,e ). In addition, WT but not Tnfa −/− granulocytes rescued survival of the recipient mice and led to faster recovery of white and red blood cells in the peripheral blood ( Fig. 4f,g) . Imaging analyses showed that, during regeneration, granulocytes preferentially localized to sinusoids: 76% of granulocytes were found within 5 µm of a sinusoid, whereas a much smaller fraction (14%) localized to Nestin-GFP bright arterioles (Fig. 4h,i) . B lymphocytes, which did not induce regeneration (Fig. 2b) , showed fewer interactions with BM vessels than did granulocytes (Supplementary Fig. 8b,c) . Granulocyte recruitment to regenerating vessels was independent of CXCR4 and CXCR2 (Supplementary Fig. 8d-f) , the major receptors that regulate neutrophil trafficking during homeostasis 30 , indicating that other mechanisms regulate granulocyte recruitment to injured vessels. Adoptive granulocyte transfer did not promote survival and vascular regeneration in Tnfr1 −/− ; Tnfr2 −/− mice, as compared with control mice, after transplantation (Fig. 4j,k) , suggesting that the cross-talk between granulocytes and endothelial cells is direct.
To confirm that granulocyte-derived TNFα does not promote regeneration via effects on hematopoietic cells, we transplanted WT recipients with an initial graft of 10 5 WT or Tnfr1 −/− ; Tnfr2 −/− BMNCs, then performed adoptive transfer of WT granulocytes. We found less peripheral blood and BM hematopoietic recovery in mice transplanted with Tnfr1 −/− ; Tnfr2 −/− as compared with WT BMNCs (Supplementary Fig. 9a,b) , in agreement with previous findings showing that, during regeneration, TNFα acts on HSPCs and promotes engraftment 31 . Mice transplanted with Tnfr1 −/− ; Tnfr2 −/− BMNCs also showed delayed vascular regeneration ( Supplementary  Fig. 9c) , which was associated with a deficit in granulocyte production (Supplementary Fig. 9a ). Adoptive transfer of WT granulocytes prevented death (Supplementary Fig. 9d ) and dramatically increased vascular and hematopoietic recovery ( Supplementary  Fig. 9a,b ) in mice transplanted with either WT or Tnfr1 −/− ; Tnfr2 −/− BMNCs. These data demonstrate that granulocyte-derived TNFα does not act on hematopoietic cells or consequently promote vascular regeneration.
Myeloid cells are key players in vascular remodeling and regeneration in many tissues 26, 28, 32 . Our data demonstrate that granulocytes, the most abundant cells in the BM, interact with the BM microenvironment and drive vascular regeneration specifically via TNFα. Because endothelial-cell-derived factors (for example, Notch ligands, EGF and pleiotrophin) 1, 3, 16, 17, 33 and vessel regeneration 2, 4, 19 are necessary for hematopoietic recovery, these results suggest the existence of a positive feedback loop after BM injury. In this loop, endothelial-cell regeneration drives hematopoietic-progenitor proliferation and generation of granulocytes, thus supporting further vessel regeneration. Our results also indicate that granulocytes overcome the inhibition of vascular regeneration induced by hematopoietic progenitors 21 . After transplantation, HSCs and multipotent progenitors preferentially generate myeloid cells 34 , a preference believed to satisfy the physiological demand for peripheral neutrophils and to prevent infections. Our results suggest that this myeloid bias, by generating granulocytes, might also contribute to recovery by promoting vessel regeneration.
The effects of TNFα on HSPC function are controversial. Some reports have suggested that TNFα acts on HSPCs and thereby promotes their maintenance in the steady state and engraftment during regeneration 31, 35, 36 . Other reports have suggested that TNFα acts on HSPCs and inhibits their function during homeostasis, and that TNFα-receptor blockade before transplantation promotes HSPC survival 37, 38 . Our results support the notion that TNFα has proregenerative effects on HSPCs and further indicate that, beyond their effects on hematopoietic cells, granulocytes use TNFα to drive vascular regeneration. Granulocytes also produce other proregenerative factors, such as VEGF, which is necessary for BM vascular regeneration 2 and can recruit angiogenic myeloid cells to the heart 32 , and pleiotrophin, which promotes hematopoietic recovery by inducing Ras activation in HSPCs 16, 17 . Future studies are needed to determine whether these factors cooperate with TNFα in granulocyte-driven regeneration.
Our data suggest that the composition and cellular output of the initial graft affect the recovery of host vessels and hematopoietic cells and thus may have implications in the context of clinical HSC transplantation. In patients especially vulnerable to myeloablation, such as those with DNA-repair defects or those in whom the BM stroma has been damaged by prior chemotherapy treatment 39, 40 , treatment with BM granulocytes could potentially be used to ameliorate vascular injury and promote hematopoietic recovery.
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AUtHOR cOntRIBUtIOnS
Peripheral-blood analyses. Blood was collected from the facial vein in tubes containing EDTA. White-blood-cell, red-blood-cell and platelet counts were obtained with an Advia Counter (Siemens) or a Hemavet 950 (Drew Scientific). Before flow cytometry staining and analyses, red blood cells in peripheral blood were lysed once by the addition of 1 ml of RBC lysis buffer (150 mM NH 4 Cl, 10 mM NaCO 3 and 0.1 mM EDTA). Cells were immediately decanted by centrifugation, resuspended in ice-cold PEB and used in subsequent assays.
Collagenase/dispase digestion. To purify the stromal-cell fraction of the bone marrow (including endothelial cells), we used a modified version of the serial digestion protocol developed by the Simmons laboratory 49 . Digestion buffer was made with 2 mg/ml collagenase type IV (Gibco, 17104-019) and 3 mg/ml dispase (Gibco, 17105-041) dissolved in room-temperature PBS. We harvested the BM by flushing each tibia with 1 ml of digestion buffer into a 5 ml polypropylene snap-cap tube containing another 1 ml of digestion buffer. We mixed the tubes vigorously by hand and incubated them at 37 °C for 5-7 min. After the first incubation, the tubes were mixed vigorously by hand and then incubated at 37 °C for another 5-7 min. After this second incubation, we collected the supernatant, taking care to leave any macroscopic clumps in the tube. We transferred the digested cells to a tube containing 5 ml of ice-cold PEB. Then we added 1 ml of digestion buffer to the snap-cap tubes, and the process above was repeated until all macroscopic pieces of bone marrow had been digested. The red blood cells were lysed once with RBC lysis buffer, filtered through a 100-µm filter (Greiner Bio-one, 542-000) and then immediately spun down in a centrifuge. The cells were resuspended in 1 ml of ice-cold PEB and used for subsequent analyses.
FACS analyses. Cells were stained for 30 min in PEB buffer with the indicated antibodies and analyzed in a BD LSRFortessa (BD Biosciences) instrument or FACS-purified with a BD FACS Aria II or a Synergy SY3200 (Sony) cell sorter. Dead cells and doublets were excluded on the basis of FSC and SSC distribution and DAPI (Sigma) exclusion. Data was analyzed with FACS Diva software 8.0 (BD Biosciences). Antibodies used were against B220 (clone RA3-6B2, cat no. 103224), CD3 (clone 145-2C11, cat no.100304), CD4 (clone GK1. 5 BP0089 from Bio X Cell); and TNFα (clone MP6-XT22, cat. no. 506303 from BioLegend ). For cell-cycle analyses, cells were first fixed with 4% paraformaldehyde for 20 min at 4 °C, and the plasma membrane was then permeabilized with 0.1% Triton X-100 for 20 min at 4 °C. The cells were stained for 30 min in PEB buffer containing 0.1% Triton X-100 with Ki67 (cat no. 50-5698-82 from ThermoFisher). Finally, the cells were incubated in PEB buffer containing DAPI for 1 h at room temperature before being analyzed as described above. Apoptotic cells were detected with a CellEvent Caspase-3/7 Green Flow Cytometry Assay Kit from Life Technologies (cat. no. C10427). Apoptotic cells were analyzed as described above.
Primary and secondary bone marrow transplantation and adoptive transfer experiments.
Recipient male mice were conditioned with two doses (600 rads with a 137 Cs source) administered 3 h apart and were immediately transplanted with the indicated amount of donor BMNC (retro-orbital injection). For adoptive transfer experiments, the indicated doses of FACS-purified hematopoietic cells were resuspended in 200 µl of PBS and injected retro-orbitally into the recipient mice. Owing to the known circadian-rhythm effects in granulocytes and HSCs 10,46-48 , we performed adoptive transfers at zeitgeber times 10-12 in mice under standard (12-h light/12-h dark) cycles.
In vivo granulocyte ablation. For diphtheria-toxin-mediated granulocyte ablation, we treated mice with daily intraperitoneal injections of diphtheria toxin (D0564, Sigma) (0.25 µg/mouse/d) for 1 week starting 1 week after transplantation. For anti-Ly6G-mediated depletion experiments, we treated mice with 100 µg (intraperitoneal) of anti-Ly6G (clone 1A8, BP0075-1 from Bio X Cell) or isotype-control antibody (clone 2A3, BP0089 from Bio X Cell) at days 1, 3 and 5 after transplantation. Binding of anti-Ly6G prevents staining with anti-Gr1, thereby preventing the use of Gr1 for detection of granulocytes in anti-Ly6G-injected mice. Thus, in these experiments, Ly6G + granulocytes were detected by staining BM cells with isotype or anti-Ly6G antibodies: 1 µg/ml of anti-Ly6G or isotype antibody staining was followed by staining with a secondary antibody (405418 from BioLegend).
5-fluorouracil treatment.
We injected mice (retro-orbitally) with a single dose of 250 mg of 5-fluorouracil (Sigma) per kg body weight in PBS.
Recombinant-TNFα injection.
We injected the mice (0.5 µg/mouse, intraperitoneally) with recombinant mouse TNFα (718004, BioLegend) daily. AMD3100 and SBD. AMD3100 (5 mg/kg s.c.) and SBD (0.3 mg/kg, i.p. SB225002, Sigma) were injected at days 1, 3, and 5 after transplantation and 1 h before harvest. Whole-mount immunofluorescence analyses. Imaging of the mouse BM sternal vasculature has been described previously 18 . Briefly, mice were injected (retro-orbitally) with 5 µg of Alexa Fluor 647 anti-mouse CD31 (110724, BioLegend) and 5 µg of Alexa Fluor 647 anti-mouse CD144 (138006, BioLegend). Twenty minutes later, mice were euthanized through isoflurane overdose, and the sterna were retrieved. For each sternum, we removed muscle and connective tissue with a scalpel. The sternum was then divided into segments, and each segment was cut sagittally to expose the BM cavity. Segments were fixed in 4% paraformaldehyde (Sigma) in PBS for 20 min at room temperature, washed three times in PBS and imaged immediately or incubated in blocking solution (20% goat serum (Sigma) in PBS) for 2 h before staining with antibodies. Granulocytes or B cells were detected by staining in a solution containing 2.5 µg/ml Alexa Fluor 488 anti-mouse Ly6-G (clone 1A8, BioLegend) or phycoerythrin-conjugated anti-mouse CD19 (clone 6F5, BioLegend), 5% goat serum (Sigma) in PBS for 3 d. Before imaging, each segment was glued to 35-mm dishes and imaged in a Leica SP5 upright confocal microscope with a 20× longdistance water-immersion-objective hybrid detectors and Leica Application Suite Advanced Fluorescence software. We acquired z stacks (2.98 µm between slices) 20-200 µm in thickness, depending on the position of the bone. Each slice measured 434.17 µm along the x axis and 434.17 µm along the y axis and was 1,024 × 1,024 pixels. All images were acquired at room temperature. For Alexa Fluor 647, the wavelength of the excitation laser was 647 nm, and emitted light was detected between 660 and 720 nm. For Alexa Fluor 488, the wavelength of the excitation laser was 488 nm, and emitted light was detected between 500 and 540 nm. For phycoerythrin, the wavelength of the excitation laser was 560 nm, and emitted light was detected from 570 to 600 nm. We used Fiji 50 software to generate 3D reconstructions and maximum projections from each image. Blood vessel numbers and lengths were counted manually in 3D reconstructions to distinguish true vessels (with lumens) from vascular sheets (lacking lumens). Composite images of each sternum were assembled by stitching together the maximum projection images in Power Point (Microsoft).
Quantification of inflammatory cytokines in plasma and bone mar-

Vascular permeability.
Mice received 200 µl of 0.5% Evans blue dye (Sigma-Aldrich, E2129) in PBS via retro-orbital injection. Thirty minutes later, mice were euthanized and perfused with 5 ml of PBS to remove excess Evans blue from the vessels. For bone marrow harvesting, each femur was flushed with 1 ml of ice-cold PEB. The cells were centrifuged, and the supernatant containing the extravasated Evans blue was removed and placed in a clean 1.5-ml tube. For analysis of the amount of Evans blue in the supernatant, samples were placed in a 96-well plate and read with a Spectramax 340PC instrument from Molecular Devices with the measured absorbance set to 610 nm. Pathology analyses. Mice were euthanized through isoflurane overdose. Liver, lung and intestine tissues were removed, processed, embedded in paraffin, sectioned and stained with hematoxylin/eosin by a necropsy technician in the In vivo Animal Core (IVAC) facility at the University of Michigan Medical School. We received the sections and did imaging analysis with an Olympus BX51 with a 20× dry objective lens. Images were captured with a DP-70 digital camera and the associated software. In-depth pathological analysis was performed by the veterinary pathologist of the IVAC.
Statistics.
In most graphs of data, the actual values for each mouse are plotted, and the means are indicated. In other graphs, the means and standard errors are plotted. Sample size was not predetermined, and all mice were included in the analyses. Mice were randomly allocated to the different groups on the basis of cage and litter size. For all experiments, we aimed to have the same number of mice in the control and experimental groups. For all experiments, at the time of analyses, the investigator was blinded to the group allocation. The only exception was the blood vessel quantification in 3D reconstructions of sternal segments. Statistical differences were calculated with two-tailed two sample t tests (for experiments with two groups) or ANOVA (3 or more groups) on log-transformed data, or log-rank tests for survival analysis. Corresponding author(s): Daniel Lucas
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Experimental design 1. Sample size
Describe how sample size was determined. Sample size was not predetermined, as a default we tried to have the same number of mice in each group and analyze at least 2-3 mice per experiment.
Data exclusions
Describe any data exclusions. No data were excluded from these analyses
Replication
Describe whether the experimental findings were reliably reproduced.
Each experiment was repeated at least 2-3 times as indicated in each panel.
Experimental findings were reliably reproduced between experiments.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were randomly allocated to each group.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For all experiments, at the time of analyses, the investigator was blinded to the group allocation. The only exception was the blood vessel quantification in 3D reconstructions of sternal segments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
blood cells were lysed once using RBC Lysis Buffer, filtered through a 100 μm filter (Greiner Bio-one, 542-000), and then immediately spun down in the centrifuge. The cells were resuspended in 1 ml of ice-cold PEB and used for subsequent analyses. Cells were stained for 30 minutes in PEB buffer and analyzed in one of the instruments indicated below.
6. Identify the instrument used for data collection. Data was collected in a BD LSRFortessa (BD Biosciences). Cells were FACSpurified using a BD FACS Aria II or a Synergy SY3200 Cell sorter (Sony) 7. Describe the software used to collect and analyze the flow cytometry data.
Samples were analyzed using BD FacsDiva version 8.0
8. Describe the abundance of the relevant cell populations within post-sort fractions.
Sorting efficiency was quantified by reanalyzing the sorted cells in one of the instruments above to ensure more than 95% purity 9. Describe the gating strategy used. Gating based on FSC area vs width and SSC area vs height and DAPI viability dye staining were used to gate live, single, cells. Gates were drawn as shown in the relevant panels or as described in Nat Med. 2014 Nov;20 (11):1315-20. Positive and negative populations were defined by using fluorescence minus one controls, or staining cells purified from mice lacking the detected protein or appropriate positive and negative controls.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
